CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Total Revenues	$ 380,488	$ 50,062	$ 545,646	$ 54,152
Costs and Expenses
Costs of revenue	423,861	22,923	496,643	95,628
Research, development and manufacturing operations	901,850	176,067	1,629,886	335,532
Selling, general and administrative	800,416	119,870	1,362,126	189,393
Depreciation and amortization	12,064	55,389	24,936	111,651
Total Costs and Expenses	2,138,191	374,249	3,513,591	732,204
Loss from Operations	(1,757,703)	(324,187)	(2,967,945)	(678,052)
Other Income/(Expense)
Other income/(expense), net			800	259,600
Interest expense	(169,472)	(1,032,774)	(731,550)	(2,263,466)
Change in fair value of derivatives and gain/(loss) on extinguishment of liabilities, net	234,236		3,852,140	7,717,150
Total Other Income/(Expense)	64,764	(1,032,774)	3,121,390	5,713,284
Net Income/(Loss)	$ (1,692,939)	$ (1,356,961)	$ 153,445	$ 5,035,232
Net Income/(Loss) Per Share (Basic)	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Income/(Loss) Per Share (Diluted)	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Weighted Average Common Shares Outstanding (Basic)	18,345,583,473	5,168,303,334	18,258,466,806	4,963,732,492
Weighted Average Common Shares Outstanding (Diluted)	18,345,583,473	5,168,303,334	163,341,800,140	65,019,562,492
Products
Total Revenues	$ 380,488	$ 50,062	$ 545,646	$ 54,152